Bio-Rad Laboratories (BIO) to Release Quarterly Earnings on Thursday

Bio-Rad Laboratories (NYSE:BIO) is expected to issue its quarterly earnings data after the market closes on Thursday, February 13th. Analysts expect the company to announce earnings of $2.86 per share and revenue of $679.75 million for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Bio-Rad Laboratories Trading Down 3.7 %

Shares of BIO opened at $314.82 on Wednesday. The company has a debt-to-equity ratio of 0.16, a quick ratio of 4.52 and a current ratio of 6.14. Bio-Rad Laboratories has a one year low of $262.12 and a one year high of $387.99. The stock has a 50-day moving average price of $340.56 and a 200 day moving average price of $336.91. The company has a market capitalization of $8.81 billion, a P/E ratio of -11.52 and a beta of 0.90.

Analysts Set New Price Targets

BIO has been the subject of a number of research analyst reports. StockNews.com upgraded shares of Bio-Rad Laboratories from a “hold” rating to a “buy” rating in a research note on Friday, November 1st. Citigroup boosted their target price on shares of Bio-Rad Laboratories from $400.00 to $450.00 and gave the stock a “buy” rating in a research report on Thursday, October 31st. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $481.00 price target on shares of Bio-Rad Laboratories in a research report on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Bio-Rad Laboratories presently has a consensus rating of “Moderate Buy” and a consensus target price of $394.20.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets.